- Experience in both small/mid-cap healthcare investing and early stage drug development.
- Authored/Co-authored high profile scientific papers (including PNAS, Cell, and Nature SMB) and a selected speaker at scientific conferences.
- 12 years of experience as a biomedical scientist in biochemistry, microbiology, and neurobiology research laboratories.
Michael joined Foresite Capital in 2016 and previously was an equity analyst at DAFNA Capital Management, a long-short healthcare hedge fund.
Michael has experience investing across diverse therapeutic areas including oncology, autoimmune, and rare diseases. Previously he was scientist and senior scientist at Vault Pharma Inc., and worked in early stage drug development, business development, and IP portfolio management. He received his Ph.D. in Biochemistry from Caltech, where he was awarded an NSF graduate research fellowship, and B.S. in Molecular, Cell and Developmental Biology from UCLA. He has over 12 years of experience as a research scientist and has authored numerous publications in top-tier biomedical research journals.